News Search Results
Apr 22, 2025, 13:28 ET INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANA
April 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA) and certain officers. The class action, filed in the United States
More news about: Pomerantz LLP
Apr 22, 2025, 11:10 ET Tampa General Hospital Appoints Jennifer Crabtree as President of the Tampa Medical & Research District
Crabtree will lead the strategic direction and ongoing development of the TMRD, a growing hub of world-class clinical care, academics, research and biotechnology. TAMPA, Fla., April
More news about: Tampa General Hospital
Apr 22, 2025, 10:35 ET Industrial Automation Control Market Forecasted to Reach $391.63 Billion by 2031, Growing at a 10.7% CAGR| Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Apr 22, 2025, 10:30 ET Humanized Mouse and Rat Model Market worth US$409.8 million in 2030 with 8.2% CAGR | MarketsandMarkets™
humanized models in drug discovery research, rising demand for personalized medicine, and increasing R&D activities in the pharmaceutical & biotechnology industry are contributing to market growth. Additionally, growing demand for humanized mouse models, preference for humanized PDX models, and the
More news about: MarketsandMarkets
Apr 22, 2025, 10:01 ET Veterinary Poc Hematology Diagnostics Market to Reach $1.7 Bn by 2027 in the short run and $2.3 Bn by 2030 Globally, at 9.3% CAGR: Allied Market Research
The major players in the at home gene testing industry include Volition, Virbac, Fujifilm Holdings Corporation, Siemens AG, Zhejiang Pushkang Biotechnology Co., LtD., Chengdu Seamaty Technology Co., Ltd, Antech Diagnostics, Inc, IDEXX Laboratories, Inc, Zoetis Services LLC, and Bionote USA
More news about: Allied Market Research
Apr 22, 2025, 09:35 ET Theradaptive Appoints Daniel Wolf as Chief Financial Officer, Continuing Executive Transformation
Md., April 22, 2025 /PRNewswire/ -- Theradaptive, a clinical-stage biotechnology company pioneering targeted protein therapeutics for tissue regeneration, is pleased to announce the appointment of Daniel
More news about: Theradaptive
Apr 22, 2025, 09:30 ET Neuvian Skincare Launches: Redefining Beauty through Advanced Scientific Discovery
officially launches a luxury beauty-tech brand, pioneering a new era in science-driven, high-performance skincare. Leveraging organic chemistry, biotechnology and epigenetics, Neuvian introduces its proprietary Bioidentical Dual Peptide (BDP) Technology™ and Smart Release Polymer Technology™ for cellular-level
More news about: Neuvian Skincare
Apr 22, 2025, 08:31 ET MetaVia Reports Additional Positive Top-Line Results From the MAD Part 2 of Its Phase 1 Study of DA-1726, a Novel 3:1 Ratio GLP-1 and Glucagon Dual Receptor Agonist to Treat Obesity, Further Demonstrating Its Best-In-Class Potential
April 22, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today reported additional top-line results from the multiple ascending dose (MAD) Part
More news about: MetaVia Inc.
Apr 22, 2025, 08:24 ET Robles BioCeutics Welcomes Experienced Drug Developer Dr. Radu Pislariu to Scientific Advisory Board
April 22, 2025 /PRNewswire/ -- Robles BioCeutics, a regenerative dermatology biotechnology company pioneering next-generation skincare solutions using stem cell and senolytics technologies, is pleased to welcome Dr. Radu Pislariu to its
More news about: Robles BioCeutics
Apr 22, 2025, 08:00 ET BioVaxys and SpayVac-for-Wildlife Expand License Agreement Into Commercial Aquaculture
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about
More news about: BioVaxys Technology Corp.
Apr 22, 2025, 07:00 ET RBL LLC welcomes Devyn Smith to board of directors
connections across the biotech ecosystem will be invaluable in helping us identify the most promising opportunities." "Devyn's reputation in the biotechnology industry speaks for itself," said
More news about: RBL LLC
Apr 22, 2025, 07:00 ET Tagworks Pharmaceuticals Announces FDA Clearance of IND Application and Initiation of Phase 1 Clinical Trial for TGW101 and Appoints Keith Orford, MD, PhD, as Chief Medical Officer
with the appointment of Keith Orford, MD, PhD, as CMO. Dr. Orford's proven track record as a physician, scientist, and executive leader at several biotechnology companies will support Tagworks' position as a leader and innovator in cancer drug development. "We are pleased to welcome Keith and look
More news about: Tagworks Pharmaceuticals BV
Apr 22, 2025, 07:00 ET Tagworks Pharmaceuticals Announces FDA Clearance of IND Application and Initiation of Phase 1 Clinical Trial for TGW101 and Appoints Keith Orford, MD, PhD, as Chief Medical Officer
with the appointment of Keith Orford, MD, PhD, as CMO. Dr. Orford's proven track record as a physician, scientist, and executive leader at several biotechnology companies will support Tagworks' position as a leader and innovator in cancer drug development. "We are pleased to welcome Keith and look
More news about: Tagworks Pharmaceuticals BV
Apr 22, 2025, 06:00 ET Danaher Reports First Quarter 2025 Results
C Impairment charges related to a facility in the Biotechnology segment recorded in the three-month period ended March 28, 2025 ($15 million pretax as reported in this line item, $11 million after-tax).
More news about: Danaher Corporation
Apr 22, 2025, 05:45 ET Sana Biotechnology, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights - SANA
April 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sana Biotechnology, Inc. ("Sana Biotechnology, Inc." or the "Company") (NASDAQ: SANA) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Apr 22, 2025, 02:00 ET Onward Therapeutics Announces IMPD Approval for Its Subsidiary Emercell to Start Clinical Investigation of Allogeneic NK Cell Therapy OT-C001 in Combination with Rituximab
PARIS, April 22, 2025 /PRNewswire/ -- Onward Therapeutics SA, a biotechnology company dedicated to advancing innovative cancer immunotherapies, announced that its subsidiary, Emercell SAS, has received Investigational Medicinal
More news about: Onward Therapeutics
Apr 21, 2025, 17:31 ET Roche's HEMLIBRA Achieves Significant Uptake Across Key Hemophilia A Markets | DelveInsight
clot formation and minimize or prevent bleeding episodes. Initially, FVIII replacement was sourced from whole blood and plasma, but advances in biotechnology led to the development of recombinant FVIII (rFVIII) therapies, significantly enhancing disease management by offering more precise and efficient
More news about: DelveInsight Business Research, LLP
Apr 21, 2025, 10:15 ET Cell Based Assays Market worth US$27.55 billion by 2030 with 9.1% CAGR | MarketsandMarkets™
(US). Merck KGaA (Germany): is a leading provider of solutions and services for research, biotechnology, and pharmaceutical drug development and production in the global life sciences industry. The company offers tools, services, and digital platforms
More news about: MarketsandMarkets
Apr 21, 2025, 08:30 ET BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy
platform. Mr. Xin Chen, CEO of BGM Group, commented: "Wonder Dragon's Qingzhuan dark tea resources, combined with our biotechnology platform, will significantly advance our medicinal tea product development and distribution. By leveraging our technological expertise, we intend
More news about: BGM Group Ltd
Apr 21, 2025, 08:24 ET BIO Asia-Taiwan Kicks Off on an Expanded Scale July 23
Zone, participating companies include PharmaEssentia, MycoMagic Biotechnology, Golden Biotechnology, Foresee Pharmaceuticals, Wendy International, Formosa Pharmaceuticals, AP Biosciences, TAHO Pharmaceuticals, Charsire Biotechnology, Elixiron Immunotherapeutics, BoYen Therapeutics, WCC Biomedical, Transin
More news about: Taiwan Bio Industry Organization
Apr 21, 2025, 08:00 ET Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals
approximately 60.6 million shares on a fully-diluted basis. About Aerovate Therapeutics, Inc. Aerovate Therapeutics is a biotechnology company that was focused on improving the lives of patients with rare cardiopulmonary disease. For more information, please visit
More news about: Aerovate Therapeutics
Apr 21, 2025, 07:00 ET SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. (NASDAQ: SANA) between March 17, 2023 and November 4, 2024, both dates inclusive
More news about: THE ROSEN LAW FIRM, P. A.
Apr 21, 2025, 07:00 ET Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension
SHANGHAI, April 21, 2025 /PRNewswire/ -- Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for RN1871, a small interfering
More news about: Rona Therapeutics
Apr 21, 2025, 07:00 ET Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension
SHANGHAI, April 21, 2025 /PRNewswire/ -- Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for RN1871, a small interfering
More news about: Rona Therapeutics
Apr 21, 2025, 07:00 ET Acepodia Presents Preclinical Data on Antibody-Dual-Drugs Conjugation (AD2C) technology at AACR Annual Meeting 2025
therapeutic payloads using bioorthogonal click chemistry. About AcepodiaAcepodia (6976.TT) is a clinical-stage biotechnology company headquartered in Taipei and Alameda, California, advancing innovative
More news about: Acepodia Inc.